Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Coleclough

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Vaccine|March 9, 2004
Minor components of a multi-envelope HIV vaccine are recognized by type-specific T-helper cellsXiaoyan Zhan, Karen S Slobod, Sherri Surman, et al.
Vaccine|August 7, 2004
Safety and immunogenicity of intranasal murine parainfluenza virus type 1 (Sendai virus) in healthy human adultsKaren S Slobod, Jerry L Shenep, Jorge Luján-Zilbermann, et al.
Journal of Virology|July 27, 2007
A recombinant Sendai virus is controlled by CD4+ effector T cells responding to a secreted human immunodeficiency virus type 1 envelope glycoproteinScott A Brown, Julia L Hurwitz, Amy Zirkel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2003
Clustering of Th cell epitopes on exposed regions of HIV envelope despite defects in antibody activityScott A Brown, John Stambas, Xiaoyan Zhan, et al.
Viral Immunology|July 23, 2005
Recombinant Sendai virus as a novel vaccine candidate for respiratory syncytial virusToru Takimoto, Julia L Hurwitz, Xiaoyan Zhan, et al.
Journal of Virology|May 14, 2004
Recombinant Sendai virus expressing the G glycoprotein of respiratory syncytial virus (RSV) elicits immune protection against RSVToru Takimoto, Julia L Hurwitz, Chris Coleclough, et al.
AIDS Research and Human Retroviruses|February 24, 2005
T cell epitope "hotspots" on the HIV Type 1 gp120 envelope protein overlap with tryptic fragments displayed by mass spectrometryScott A Brown, Timothy D Lockey, Clive Slaughter, et al.
Vaccine|August 13, 2005
Multi-envelope HIV-1 vaccine devoid of SIV components controls disease in macaques challenged with heterologous pathogenic SHIVXiaoyan Zhan, Louis N Martin, Karen S Slobod, et al.
AIDS Research and Therapy|April 30, 2005
Clade, Country and Region-specific HIV-1 Vaccines: Are they necessary?Karen S Slobod, Chris Coleclough, Scott A Brown, et al.
Current HIV Research|April 28, 2005
HIV vaccine rationale, design and testingKaren S Slobod, Chris Coleclough, Mattia Bonsignori, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Vaccine|March 9, 2004
Minor components of a multi-envelope HIV vaccine are recognized by type-specific T-helper cellsXiaoyan Zhan, Karen S Slobod, Sherri Surman, et al.
Vaccine|August 7, 2004
Safety and immunogenicity of intranasal murine parainfluenza virus type 1 (Sendai virus) in healthy human adultsKaren S Slobod, Jerry L Shenep, Jorge Luján-Zilbermann, et al.
Journal of Virology|July 27, 2007
A recombinant Sendai virus is controlled by CD4+ effector T cells responding to a secreted human immunodeficiency virus type 1 envelope glycoproteinScott A Brown, Julia L Hurwitz, Amy Zirkel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2003
Clustering of Th cell epitopes on exposed regions of HIV envelope despite defects in antibody activityScott A Brown, John Stambas, Xiaoyan Zhan, et al.
Viral Immunology|July 23, 2005
Recombinant Sendai virus as a novel vaccine candidate for respiratory syncytial virusToru Takimoto, Julia L Hurwitz, Xiaoyan Zhan, et al.
Journal of Virology|May 14, 2004
Recombinant Sendai virus expressing the G glycoprotein of respiratory syncytial virus (RSV) elicits immune protection against RSVToru Takimoto, Julia L Hurwitz, Chris Coleclough, et al.
AIDS Research and Human Retroviruses|February 24, 2005
T cell epitope "hotspots" on the HIV Type 1 gp120 envelope protein overlap with tryptic fragments displayed by mass spectrometryScott A Brown, Timothy D Lockey, Clive Slaughter, et al.
Vaccine|August 13, 2005
Multi-envelope HIV-1 vaccine devoid of SIV components controls disease in macaques challenged with heterologous pathogenic SHIVXiaoyan Zhan, Louis N Martin, Karen S Slobod, et al.
AIDS Research and Therapy|April 30, 2005
Clade, Country and Region-specific HIV-1 Vaccines: Are they necessary?Karen S Slobod, Chris Coleclough, Scott A Brown, et al.
Current HIV Research|April 28, 2005
HIV vaccine rationale, design and testingKaren S Slobod, Chris Coleclough, Mattia Bonsignori, et al.
Pageof 1